|Bid||36.11 x 800|
|Ask||36.21 x 1000|
|Day's Range||35.96 - 36.35|
|52 Week Range||22.00 - 38.34|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Bay Area companies are gearing up for ASCO, HCP's Brisbane biotech building is on the rise and more in our Health Care Digest.
Is Principia Biopharma Inc. (NASDAQ:PRNB) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before doing days of research on it. Given their 2 and 20 payment structure, hedge funds have more incentives and resources than the average investor. The funds […]
The direct benefit for Principia Biopharma Inc. (NASDAQ:PRNB), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. However, the trade-off Read More...
Gilead's CEO search, Amyris' cannabis consideration and Principia's opportunity in this week's Health Care Digest.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Nov. 29) Allakos Inc (NASDAQ: ALLK ) Emergent Biosolutions Inc ...
Biotech companies must do more to train, mentor and guide millennials, including pairing them with older colleagues, according to members of a recent panel.